Clinical trial
Evaluation of the Effectiveness of Intrarenal Dioxidine Metaphylaxis for Preventing Recurrence of Infection Stones After Percutaneous Nephrolithotripsy
NCT07393711 is registered in ClinicalTrials.gov with West Kazakhstan Marat Ospanov Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effectiveness of Intrarenal Dioxidine Metaphylaxis for Preventing Recurrence of Infection Stones After Percutaneous Nephrolithotripsy
- Lead sponsor
- West Kazakhstan Marat Ospanov Medical University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 1, 2026
- Completion date
- December 30, 2026
- Enrollment
- 95 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.